MarketPeel
Insider Trading Intelligence
Pricing
…
VS

Vicki L. Sato

VIR
DIRECTOR · VIR BIOTECHNOLOGY, INC. · CIK 0001197020
FILING MIX · LIFETIME26%/74%
BUYS
36
SELLS
104
TOTAL VALUE
$16.67M
COMPANIES
5
ACTIVE SINCE
Feb 2020
HOLDINGS NOW
1,377,280
AVG SELL PX
$22.01
TRADE KIND
SHOWING 140 / 140
Trades · vs SPY
Loading price series…
Performance · forward returns vs SPY
103 backtested trades · 8 horizons · 42 pending
Forward-return performance of every backtestable P/S trade by Vicki L. Sato, measured at 8 horizons from 7 days to 2 years. Deduped per economic event so co-filings count once. Excess return = trade return minus SPY return over the same window.
HORIZONTRADESWIN RATEINSIDER RETURNSPY RETURNMEAN EXCESSMEDIAN EXCESST-STAT
7d103+71.84%-3.49%+0.70%-4.19%-3.11%-4.62
14d103+61.17%-3.42%+0.85%-4.28%-3.41%-3.70
30d103+55.34%-3.02%+1.36%-4.37%-2.63%-2.70
60d103+58.25%-3.98%+2.36%-6.43%-9.47%-3.06
90d103(1 pending)+61.76%-6.09%+3.50%-9.82%-11.92%-4.08
180d103(7 pending)+73.96%-16.37%+4.79%-21.90%-33.06%-6.99
1y103(13 pending)+84.44%-33.93%+6.28%-40.21%-39.34%-13.35
2y103(21 pending)+92.68%-53.27%+20.84%-74.11%-66.49%-27.14
How to read this: Insider Returnis the average raw return of the filer's trades over the horizon. SPY Return is what SPY did over those same windows — reference only, not a comparison. The headline alpha number is Mean Excess = Insider − SPY; green means the filer beat SPY, red means they trailed it. Win rate is the share of individual trades where the filer beat SPY. T-statvalues above 2 mean the alpha is unlikely to be chance given the sample size. "Pending" counts trades where the horizon hasn't elapsed yet; their stats are not included in the row average.
Holdings over time
VIR · 1,078,391 shares · as of May 1, 2026
0415,196830,3911,245,5871,660,782202120222023202420252026SHARES HELD
Trading cadence · quarterly flow
BUY ● SELL ●
2020
2020
2020
2020
2021
2021
2021
2021
2022
2022
2022
2022
2023
2023
2023
2023
2024
2024
2024
2024
2025
2025
2025
2025
2026
2026
FLOW · 36 buys / 104 sellsCOVERAGE · 26 quarters
Form 4 filings · all activity
COMPANYTYPESHARESPRICEVALUEHELD AFTERTRADE DATEFILEDDETAILS
ALLO
ALLOGENE THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
95,400——95,400Jun 18, 2026Jun 23, 2026 ↗View →
VIR
VIR BIOTECHNOLOGY, INC.
SALE10b5-1
10b5-1 plan
22,000$10.05$221.0K1,078,391May 1, 2026May 4, 2026 ↗View →
VIR
VIR BIOTECHNOLOGY, INC.
SALE10b5-1
10b5-1 plan
22,000$9.07$199.6K1,100,391Apr 1, 2026Apr 2, 2026 ↗View →
VIR
VIR BIOTECHNOLOGY, INC.
SALE10b5-1
10b5-1 plan
200$9.98$2.0K1,122,391Mar 2, 2026Mar 3, 2026 ↗View →
VIR
VIR BIOTECHNOLOGY, INC.
SALE10b5-1
10b5-1 plan
21,800$9.50$207.2K1,122,591Mar 2, 2026Mar 3, 2026 ↗View →
VIR
VIR BIOTECHNOLOGY, INC.
SALE
42,377——0Feb 24, 2026Feb 25, 2026 ↗View →
VIR
VIR BIOTECHNOLOGY, INC.
SALE10b5-1
10b5-1 plan
42,177$9.75$411.3K1,144,591Feb 24, 2026Feb 25, 2026 ↗View →
VIR
VIR BIOTECHNOLOGY, INC.
PURCHASE
42,377$1.49$62.9K1,186,768Feb 24, 2026Feb 25, 2026 ↗View →
VIR
VIR BIOTECHNOLOGY, INC.
SALE10b5-1
10b5-1 plan
200$10.26$2.1K1,144,391Feb 24, 2026Feb 25, 2026 ↗View →
VIR
VIR BIOTECHNOLOGY, INC.
SALE10b5-1
10b5-1 plan
22,000$7.71$169.7K1,144,391Feb 2, 2026Feb 3, 2026 ↗View →
VIR
VIR BIOTECHNOLOGY, INC.
SALE10b5-1
10b5-1 plan
22,000$5.93$130.4K1,166,391Jan 2, 2026Jan 5, 2026 ↗View →
VIR
VIR BIOTECHNOLOGY, INC.
SALE10b5-1
10b5-1 plan
22,000$6.00$132.1K1,188,391Dec 1, 2025Dec 2, 2025 ↗View →
VIR
VIR BIOTECHNOLOGY, INC.
SALE10b5-1
10b5-1 plan
22,000$5.64$124.0K1,210,391Nov 3, 2025Nov 4, 2025 ↗View →
VIR
VIR BIOTECHNOLOGY, INC.
SALE10b5-1
10b5-1 plan
22,000$5.84$128.4K1,232,391Oct 1, 2025Oct 2, 2025 ↗View →
VIR
VIR BIOTECHNOLOGY, INC.
SALE10b5-1
10b5-1 plan
22,000$4.99$109.8K1,254,391Sep 2, 2025Sep 3, 2025 ↗View →
VIR
VIR BIOTECHNOLOGY, INC.
SALE10b5-1
10b5-1 plan
22,000$4.99$109.7K1,276,391Aug 1, 2025Aug 4, 2025 ↗View →
VIR
VIR BIOTECHNOLOGY, INC.
SALE10b5-1
10b5-1 plan
22,000$5.10$112.2K1,298,391Jul 1, 2025Jul 2, 2025 ↗View →
ALLO
ALLOGENE THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
144,400——144,400Jun 18, 2025Jun 20, 2025 ↗View →
VIR
VIR BIOTECHNOLOGY, INC.
PURCHASEGRANT
Stock grant
16,000——16,000May 30, 2025Jun 2, 2025 ↗View →
VIR
VIR BIOTECHNOLOGY, INC.
PURCHASEGRANT
Stock grant
8,000——1,320,391May 30, 2025Jun 2, 2025 ↗View →
VIR
VIR BIOTECHNOLOGY, INC.
SALE10b5-1
10b5-1 plan
10,960$12.52$137.2K1,312,391Jan 8, 2025Jan 8, 2025 ↗View →
DNLI
DENALI THERAPEUTICS INC.
SALE10b5-1
10b5-1 plan
3,080$20.91$64.4K107,976Jan 2, 2025Jan 3, 2025 ↗View →
DNLI
DENALI THERAPEUTICS INC.
SALE10b5-1
10b5-1 plan
1,020$30.00$30.6K111,056Nov 7, 2024Nov 12, 2024 ↗View →
DNLI
DENALI THERAPEUTICS INC.
SALE10b5-1
10b5-1 plan
3,080$27.07$83.4K112,076Nov 1, 2024Nov 5, 2024 ↗View →
DNLI
DENALI THERAPEUTICS INC.
SALE10b5-1
10b5-1 plan
1,020$30.00$30.6K115,156Sep 13, 2024Sep 16, 2024 ↗View →
DNLI
DENALI THERAPEUTICS INC.
SALE10b5-1
10b5-1 plan
2,980$24.99$74.5K116,276Sep 3, 2024Sep 4, 2024 ↗View →
DNLI
DENALI THERAPEUTICS INC.
SALE10b5-1
10b5-1 plan
100$25.37$2.5K116,176Sep 3, 2024Sep 4, 2024 ↗View →
DNLI
DENALI THERAPEUTICS INC.
SALE10b5-1
10b5-1 plan
2,980$22.12$65.9K119,356Jul 1, 2024Jul 3, 2024 ↗View →
DNLI
DENALI THERAPEUTICS INC.
SALE10b5-1
10b5-1 plan
100$22.86$2.3K119,256Jul 1, 2024Jul 3, 2024 ↗View →
ALLO
ALLOGENE THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
61,475——162,575Jun 5, 2024Jun 7, 2024 ↗View →
ALLO
ALLOGENE THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
95,541——95,541Jun 5, 2024Jun 7, 2024 ↗View →
DNLI
DENALI THERAPEUTICS INC.
PURCHASEGRANT
Stock grant
5,967——122,336May 31, 2024Jun 4, 2024 ↗View →
DNLI
DENALI THERAPEUTICS INC.
PURCHASEGRANT
Stock grant
17,901——17,901May 31, 2024Jun 4, 2024 ↗View →
VIR
VIR BIOTECHNOLOGY, INC.
PURCHASEGRANT
Stock grant
16,000——16,000May 30, 2024Jun 3, 2024 ↗View →
VIR
VIR BIOTECHNOLOGY, INC.
PURCHASEGRANT
Stock grant
8,000——1,323,351May 30, 2024Jun 3, 2024 ↗View →
DNLI
DENALI THERAPEUTICS INC.
SALE10b5-1
10b5-1 plan
1,674$20.39$34.1K116,369May 15, 2024May 17, 2024 ↗View →
DNLI
DENALI THERAPEUTICS INC.
SALE10b5-1
10b5-1 plan
1,666$18.29$30.5K118,043Apr 15, 2024Apr 17, 2024 ↗View →
DNLI
DENALI THERAPEUTICS INC.
SALE10b5-1
10b5-1 plan
1,666$20.10$33.5K119,709Mar 15, 2024Mar 19, 2024 ↗View →
DNLI
DENALI THERAPEUTICS INC.
SALE10b5-1
10b5-1 plan
1,666$18.37$30.6K121,375Feb 15, 2024Feb 20, 2024 ↗View →
DNLI
DENALI THERAPEUTICS INC.
SALE10b5-1
10b5-1 plan
1,666$18.42$30.7K123,041Jan 16, 2024Jan 18, 2024 ↗View →
DNLI
DENALI THERAPEUTICS INC.
SALE10b5-1
10b5-1 plan
1,666$23.39$39.0K124,707Dec 15, 2023Dec 18, 2023 ↗View →
DNLI
DENALI THERAPEUTICS INC.
SALE10b5-1
10b5-1 plan
1,666$19.13$31.9K126,373Nov 15, 2023Nov 16, 2023 ↗View →
DNLI
DENALI THERAPEUTICS INC.
SALE10b5-1
10b5-1 plan
1,666$20.66$34.4K128,039Oct 16, 2023Oct 18, 2023 ↗View →
DNLI
DENALI THERAPEUTICS INC.
SALE10b5-1
10b5-1 plan
40$24.35$974129,705Sep 15, 2023Sep 19, 2023 ↗View →
DNLI
DENALI THERAPEUTICS INC.
SALE10b5-1
10b5-1 plan
1,626$23.60$38.4K129,745Sep 15, 2023Sep 19, 2023 ↗View →
DNLI
DENALI THERAPEUTICS INC.
SALE10b5-1
10b5-1 plan
1,666$24.30$40.5K131,371Aug 15, 2023Aug 17, 2023 ↗View →
DNLI
DENALI THERAPEUTICS INC.
SALE10b5-1
10b5-1 plan
1,666$29.60$49.3K133,037Jul 17, 2023Jul 19, 2023 ↗View →
VIR
VIR BIOTECHNOLOGY, INC.
SALE10b5-1
10b5-1 plan
18,000$24.66$443.9K1,315,351Jun 30, 2023Jul 3, 2023 ↗View →
DNLI
DENALI THERAPEUTICS INC.
SALE10b5-1
10b5-1 plan
1,114$29.98$33.4K134,703Jun 28, 2023Jun 30, 2023 ↗View →
DNLI
DENALI THERAPEUTICS INC.
SALE10b5-1
10b5-1 plan
552$29.55$16.3K135,817Jun 28, 2023Jun 30, 2023 ↗View →
ALLO
ALLOGENE THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
59,649——101,100Jun 13, 2023Jun 15, 2023 ↗View →
ALLO
ALLOGENE THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
23,224——23,224Jun 13, 2023Jun 15, 2023 ↗View →
DNLI
DENALI THERAPEUTICS INC.
PURCHASEGRANT
Stock grant
12,649——12,649Jun 1, 2023Jun 5, 2023 ↗View →
DNLI
DENALI THERAPEUTICS INC.
PURCHASEGRANT
Stock grant
4,216——136,369Jun 1, 2023Jun 5, 2023 ↗View →
VIR
VIR BIOTECHNOLOGY, INC.
PURCHASEGRANT
Stock grant
6,027——1,333,351May 22, 2023May 24, 2023 ↗View →
VIR
VIR BIOTECHNOLOGY, INC.
PURCHASEGRANT
Stock grant
12,054——12,054May 22, 2023May 24, 2023 ↗View →
VIR
VIR BIOTECHNOLOGY, INC.
SALE
17,935$22.59$405.1K1,327,324Mar 8, 2023Mar 9, 2023 ↗View →
VIR
VIR BIOTECHNOLOGY, INC.
SALE
627$29.00$18.2K1,345,259Feb 8, 2023Feb 9, 2023 ↗View →
VIR
VIR BIOTECHNOLOGY, INC.
SALE
17,288$28.35$490.2K1,345,886Feb 8, 2023Feb 9, 2023 ↗View →
VIR
VIR BIOTECHNOLOGY, INC.
SALE
17,915$25.83$462.8K1,363,174Jan 9, 2023Jan 10, 2023 ↗View →
VIR
VIR BIOTECHNOLOGY, INC.
SALE
17,915$25.81$462.4K1,381,089Dec 8, 2022Dec 9, 2022 ↗View →
VIR
VIR BIOTECHNOLOGY, INC.
SALE
17,915$27.38$490.5K1,399,004Nov 8, 2022Nov 9, 2022 ↗View →
VIR
VIR BIOTECHNOLOGY, INC.
SALE
17,915$20.67$370.3K1,416,919Oct 10, 2022Oct 11, 2022 ↗View →
VIR
VIR BIOTECHNOLOGY, INC.
SALE
17,915$21.90$392.3K1,434,834Sep 8, 2022Sep 9, 2022 ↗View →
VIR
VIR BIOTECHNOLOGY, INC.
SALE
17,915$30.29$542.7K1,452,749Aug 8, 2022Aug 9, 2022 ↗View →
VIR
VIR BIOTECHNOLOGY, INC.
SALE
12,843$28.87$370.7K1,475,736Jul 8, 2022Jul 11, 2022 ↗View →
VIR
VIR BIOTECHNOLOGY, INC.
SALE
5,072$29.57$150.0K1,470,664Jul 8, 2022Jul 11, 2022 ↗View →
ALLO
ALLOGENE THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
22,089——41,451Jun 15, 2022Jun 17, 2022 ↗View →
ALLO
ALLOGENE THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
35,535$9.62$341.8K35,535Jun 15, 2022Jun 17, 2022 ↗View →
VIR
VIR BIOTECHNOLOGY, INC.
SALE
500$26.51$13.3K1,488,579Jun 8, 2022Jun 9, 2022 ↗View →
VIR
VIR BIOTECHNOLOGY, INC.
SALE
17,415$25.82$449.7K1,489,079Jun 8, 2022Jun 9, 2022 ↗View →
DNLI
DENALI THERAPEUTICS INC.
PURCHASEGRANT
Stock grant
17,959——17,959Jun 2, 2022Jun 6, 2022 ↗View →
DNLI
DENALI THERAPEUTICS INC.
PURCHASEGRANT
Stock grant
5,986——142,149Jun 2, 2022Jun 6, 2022 ↗View →
VIR
VIR BIOTECHNOLOGY, INC.
SALE
3,374$23.82$80.4K1,506,494May 24, 2022May 25, 2022 ↗View →
VIR
VIR BIOTECHNOLOGY, INC.
PURCHASEGRANT
Stock grant
6,405——1,509,868May 23, 2022May 25, 2022 ↗View →
VIR
VIR BIOTECHNOLOGY, INC.
PURCHASEGRANT
Stock grant
12,810——12,810May 23, 2022May 25, 2022 ↗View →
VIR
VIR BIOTECHNOLOGY, INC.
SALE
14,541$20.62$299.8K1,503,463May 9, 2022May 10, 2022 ↗View →
VIR
VIR BIOTECHNOLOGY, INC.
SALE
14,093$20.74$292.3K1,521,826Apr 28, 2022May 2, 2022 ↗View →
VIR
VIR BIOTECHNOLOGY, INC.
SALE
3,822$21.49$82.1K1,518,004Apr 28, 2022May 2, 2022 ↗View →
VIR
VIR BIOTECHNOLOGY, INC.
SALE
15,173$37.39$567.4K1,535,919Jan 18, 2022Jan 19, 2022 ↗View →
VIR
VIR BIOTECHNOLOGY, INC.
SALE
1,100$56.10$61.7K1,553,493Dec 20, 2021Dec 21, 2021 ↗View →
VIR
VIR BIOTECHNOLOGY, INC.
SALE
5,200$55.38$288.0K1,554,593Dec 20, 2021Dec 21, 2021 ↗View →
VIR
VIR BIOTECHNOLOGY, INC.
SALE
2,401$57.82$138.8K1,551,092Dec 20, 2021Dec 21, 2021 ↗View →
VIR
VIR BIOTECHNOLOGY, INC.
SALE
5,173$51.87$268.3K1,561,093Dec 20, 2021Dec 21, 2021 ↗View →
VIR
VIR BIOTECHNOLOGY, INC.
SALE
1,300$54.35$70.7K1,559,793Dec 20, 2021Dec 21, 2021 ↗View →
VIR
VIR BIOTECHNOLOGY, INC.
SALE
15,174$36.80$558.4K1,566,266Nov 26, 2021Nov 29, 2021 ↗View →
DNLI
DENALI THERAPEUTICS INC.
SALE
1,006$52.49$52.8K126,827Nov 10, 2021Nov 12, 2021 ↗View →
DNLI
DENALI THERAPEUTICS INC.
SALE
660$53.30$35.2K126,167Nov 10, 2021Nov 12, 2021 ↗View →
DNLI
DENALI THERAPEUTICS INC.
SALE
1,666$50.05$83.4K127,833Nov 1, 2021Nov 3, 2021 ↗View →
VIR
VIR BIOTECHNOLOGY, INC.
SALE
8,503$39.91$339.3K1,581,440Oct 19, 2021Oct 20, 2021 ↗View →
VIR
VIR BIOTECHNOLOGY, INC.
SALE
6,671$39.12$261.0K1,589,943Oct 19, 2021Oct 20, 2021 ↗View →
VIR
VIR BIOTECHNOLOGY, INC.
SALE
3,399$53.06$180.4K1,596,614Sep 17, 2021Sep 21, 2021 ↗View →
VIR
VIR BIOTECHNOLOGY, INC.
SALE
11,775$52.31$616.0K1,600,013Sep 17, 2021Sep 21, 2021 ↗View →
DNLI
DENALI THERAPEUTICS INC.
SALE
140$54.76$7.7K129,499Sep 15, 2021Sep 17, 2021 ↗View →
DNLI
DENALI THERAPEUTICS INC.
SALE
620$53.92$33.4K129,639Sep 15, 2021Sep 17, 2021 ↗View →
DNLI
DENALI THERAPEUTICS INC.
SALE
230$52.28$12.0K130,935Sep 15, 2021Sep 17, 2021 ↗View →
DNLI
DENALI THERAPEUTICS INC.
SALE
676$53.03$35.8K130,259Sep 15, 2021Sep 17, 2021 ↗View →
VIR
VIR BIOTECHNOLOGY, INC.
SALE
9,045$45.52$411.7K1,611,788Aug 19, 2021Aug 20, 2021 ↗View →
VIR
VIR BIOTECHNOLOGY, INC.
SALE
6,129$44.36$271.9K1,620,833Aug 19, 2021Aug 20, 2021 ↗View →
DNLI
DENALI THERAPEUTICS INC.
SALE
860$52.12$44.8K131,165Aug 18, 2021Aug 20, 2021 ↗View →
DNLI
DENALI THERAPEUTICS INC.
SALE
806$51.26$41.3K132,025Aug 18, 2021Aug 20, 2021 ↗View →
ALLO
ALLOGENE THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
19,362——19,362Jul 30, 2021Aug 3, 2021 ↗View →
ALLO
ALLOGENE THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
31,692——31,692Jul 30, 2021Aug 3, 2021 ↗View →
DNLI
DENALI THERAPEUTICS INC.
SALE
400$65.78$26.3K132,831Jul 21, 2021Jul 23, 2021 ↗View →
DNLI
DENALI THERAPEUTICS INC.
SALE
866$65.24$56.5K133,231Jul 21, 2021Jul 23, 2021 ↗View →
DNLI
DENALI THERAPEUTICS INC.
SALE
400$64.25$25.7K134,097Jul 21, 2021Jul 23, 2021 ↗View →
VIR
VIR BIOTECHNOLOGY, INC.
SALE
6,363$37.84$240.8K1,626,962Jul 19, 2021Jul 20, 2021 ↗View →
VIR
VIR BIOTECHNOLOGY, INC.
SALE
8,811$36.74$323.7K1,633,325Jul 19, 2021Jul 20, 2021 ↗View →
DNLI
DENALI THERAPEUTICS INC.
SALE
986$71.11$70.1K134,497Jun 23, 2021Jun 24, 2021 ↗View →
DNLI
DENALI THERAPEUTICS INC.
SALE
680$70.20$47.7K135,483Jun 23, 2021Jun 24, 2021 ↗View →
VIR
VIR BIOTECHNOLOGY, INC.
SALE
11,881$46.00$546.6K1,645,429Jun 21, 2021Jun 22, 2021 ↗View →
VIR
VIR BIOTECHNOLOGY, INC.
SALE
3,293$46.75$153.9K1,642,136Jun 21, 2021Jun 22, 2021 ↗View →
DNLI
DENALI THERAPEUTICS INC.
PURCHASEGRANT
Stock grant
2,074——136,163Jun 2, 2021Jun 4, 2021 ↗View →
DNLI
DENALI THERAPEUTICS INC.
PURCHASEGRANT
Stock grant
6,222——6,222Jun 2, 2021Jun 4, 2021 ↗View →
DNLI
DENALI THERAPEUTICS INC.
SALE
40$66.72$2.7K134,089May 26, 2021May 28, 2021 ↗View →
DNLI
DENALI THERAPEUTICS INC.
SALE
894$64.90$58.0K134,861May 26, 2021May 28, 2021 ↗View →
DNLI
DENALI THERAPEUTICS INC.
SALE
732$65.88$48.2K134,129May 26, 2021May 28, 2021 ↗View →
VIR
VIR BIOTECHNOLOGY, INC.
PURCHASEGRANT
Stock grant
3,374——1,657,310May 21, 2021May 25, 2021 ↗View →
VIR
VIR BIOTECHNOLOGY, INC.
PURCHASEGRANT
Stock grant
6,748——6,748May 21, 2021May 25, 2021 ↗View →
VIR
VIR BIOTECHNOLOGY, INC.
SALE
5,403$44.18$238.7K1,655,379May 19, 2021May 20, 2021 ↗View →
VIR
VIR BIOTECHNOLOGY, INC.
SALE
1,443$44.96$64.9K1,653,936May 19, 2021May 20, 2021 ↗View →
VIR
VIR BIOTECHNOLOGY, INC.
SALE
8,328$43.35$361.0K1,660,782May 19, 2021May 20, 2021 ↗View →
DNLI
DENALI THERAPEUTICS INC.
SALE
597$62.05$37.0K136,443Apr 28, 2021Apr 30, 2021 ↗View →
DNLI
DENALI THERAPEUTICS INC.
SALE
688$63.03$43.4K135,755Apr 28, 2021Apr 30, 2021 ↗View →
DNLI
DENALI THERAPEUTICS INC.
SALE
381$60.71$23.1K137,040Apr 28, 2021Apr 30, 2021 ↗View →
DNLI
DENALI THERAPEUTICS INC.
SALE
18$54.38$979139,069Mar 31, 2021Apr 1, 2021 ↗View →
DNLI
DENALI THERAPEUTICS INC.
SALE
635$56.92$36.1K137,557Mar 31, 2021Apr 1, 2021 ↗View →
DNLI
DENALI THERAPEUTICS INC.
SALE
136$57.61$7.8K137,421Mar 31, 2021Apr 1, 2021 ↗View →
DNLI
DENALI THERAPEUTICS INC.
SALE
877$55.91$49.0K138,192Mar 31, 2021Apr 1, 2021 ↗View →
DNLI
DENALI THERAPEUTICS INC.
SALE
235$60.36$14.2K140,518Mar 3, 2021Mar 4, 2021 ↗View →
DNLI
DENALI THERAPEUTICS INC.
SALE
1,050$61.52$64.6K139,468Mar 3, 2021Mar 4, 2021 ↗View →
DNLI
DENALI THERAPEUTICS INC.
SALE
266$62.29$16.6K139,202Mar 3, 2021Mar 4, 2021 ↗View →
DNLI
DENALI THERAPEUTICS INC.
SALE
115$63.37$7.3K139,087Mar 3, 2021Mar 4, 2021 ↗View →
BMY
BRISTOL MYERS SQUIBB CO
PURCHASEGRANT
Stock grant
3,054.171$62.21$190.0K75,689.427Feb 1, 2021Feb 3, 2021 ↗View →
DNLI
DENALI THERAPEUTICS INC.
PURCHASEGRANT
Stock grant
15,183——15,183Jun 3, 2020Jun 5, 2020 ↗View →
DNLI
DENALI THERAPEUTICS INC.
PURCHASEGRANT
Stock grant
3,253——3,253Jun 3, 2020Jun 5, 2020 ↗View →
VIR
VIR BIOTECHNOLOGY, INC.
PURCHASEGRANT
Stock grant
28,888——28,888May 21, 2020May 22, 2020 ↗View →
VIR
VIR BIOTECHNOLOGY, INC.
PURCHASEGRANT
Stock grant
23,649——23,649May 21, 2020Oct 13, 2020 ↗View →
BWA
BORGWARNER INC
PURCHASEGRANT
Stock grant
4,382$29.67$130.0K19,823.19Apr 29, 2020May 1, 2020 ↗View →
BMY
BRISTOL MYERS SQUIBB CO
PURCHASEGRANT
Stock grant
3,018.268$62.95$190.0K70,459.893Feb 1, 2020Feb 4, 2020 ↗View →
Other insiders · VIR
Loading peer insiders…
About this filer
CIK 0001197020
ROLE
Director
PRIMARY
VIR
COMPANIES
5
ACTIVE SINCE
Feb 2020
MARKETPEEL · /INSIDER/0001197020DATA · SEC EDGAR · FORM 4 · CONSOLIDATED TAPE
FREE · DAILY · 6 AM ET

The morning brief, before the bell.

One short email. Insider buys, congressional trades, and plain-English analysis.

Feedback